Cargando…

Appropriate therapy for implantable cardioverter defibrillators used as primary versus secondary prophylaxis

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: Implantable cardioverter defibrillators (ICD) are used for primary prevention in children highly suspicious of life-threatening arrhythmias due to family history and malignant syncope. This practice might potentially result in a lo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thuraiaiyah, J, Jensen, A S, Philbert, B T, Sondergaard, L, Jons, C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	14.5 - Device Complications and Lead Extraction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206804/ http://dx.doi.org/10.1093/europace/euad122.505

Ejemplares similares

Pulsed-field ablation in patients with permanent pacemaker or implantable cardioverter defibrillator: Is it safe?
por: Lennerz, C, et al.
Publicado: (2023)

Blood stream infection in patients with implantable-cardioverter defibrillator admitted to non-cardiology units: incidence, diagnostic work-up and outcome
por: Oezkartal, T, et al.
Publicado: (2023)

Gradually increasing impedance in patients with pacemakers and implantable defibrillators: a watchful waiting strategy
por: Maass, A, et al.
Publicado: (2023)

Safety of epinephrine-containing local anaesthesia in CIED implantations
por: Lau, Y, et al.
Publicado: (2023)

Comparison between thoracic ultrasound and chest x-ray in non-infective early complications detection after cardiac implantable electronic devices implantation procedures
por: Floris, R, et al.
Publicado: (2023)

Incidental findings at FDG PET/CT in carriers of cardiovascular implantable electronic devices
por: Diemberger, I, et al.
Publicado: (2023)

Novelty about pocket histology at cardiac implantable electronic device reopening procedures
por: Massaro, G, et al.
Publicado: (2023)

Does radiotherapy effect the voltage output of cardiac implantable electronic devices (CIEDs)?
por: Fenwick, A, et al.
Publicado: (2023)

Electric cars and high power chargers: Are they safe for patients with cardiac implantable electronic devices?
por: Lennerz, C, et al.
Publicado: (2023)

A Novel Antibiotic Delivery Approach for Salvage of Cardiovascular-Implantable Electronic Devices with Localized Infection
por: Chorin, E, et al.
Publicado: (2023)

Leadless pacemaker implantation following transvenous lead extraction: data from i-LEAPER registry
por: Mitacchione, G, et al.
Publicado: (2023)

Self-taught ultrasound-guided axillary vein access for pacemaker implantations - complication rates and outcomes
por: Kong, Q G, et al.
Publicado: (2023)

Clinical impact of capsulectomy during cardiac implantable electronic device generator replacement: a prospective randomized trial
por: Kim, H J, et al.
Publicado: (2023)

Efficacy of antibacterial envelope use in cardiac implantable electronic device infection prevention: insights from real world data
por: Ziacchi, M, et al.
Publicado: (2023)

Low incidence rate of infections associated with cardiac implantable electronic device procedures in a large real-world patient cohort
por: Imberti, J F, et al.
Publicado: (2023)

Initial results of a prospective, multicenter study on the use of a biosynthesized cellulose membrane as a separation in de novo CIED implantations
por: Starck, C T, et al.
Publicado: (2023)

Sequential use of different mechanical rotational tools greatly improves success of lead extraction
por: Bracke, F, et al.
Publicado: (2023)

Impact of right ventricular lead position on the outcomes of transvenous lead extraction
por: Miklos, M, et al.
Publicado: (2023)

Occlusion balloon during transvenous lead extraction-Lessons learned from a case series
por: Hofer, D, et al.
Publicado: (2023)

Transvenous vs. subcutaneous ICDs after transvenous device complication
por: Willy, K, et al.
Publicado: (2023)

Single center experience with a novel short rotating dilator sheath in transvenous lead extraction
por: Hofer, D, et al.
Publicado: (2023)

Complicated pocket infection in patients undergoing lead extraction - a new entity?
por: Milman, A, et al.
Publicado: (2023)

Safety and efficacy of Laser lead extraction in octo- and nonagenarians. A Subgroup Analysis from the GALLERY registry
por: Pecha, S, et al.
Publicado: (2023)

Device-related infection in a large tertiary center-Benefit of the antibacterial envelope
por: Hofer, D, et al.
Publicado: (2023)

High success and safety of transvenous lead extraction using excimer laser sheaths in more than 1700 patients: a meta-analysis
por: Rinaldi, C A, et al.
Publicado: (2023)

Procedural outcome and risk prediction in young patients undergoing transvenous lead extraction. A GALLERY subgroup analysis
por: Chung, D, et al.
Publicado: (2023)

Safety and efficacy of excimer laser powered lead extractions in obese patients: a GALLERY subgroup analysis
por: Schenker, N, et al.
Publicado: (2023)

Long‐term follow‐up of implantable cardioverter defibrillator patients with regard to appropriate therapy, complications, and mortality
por: Mattsson, Gustav, et al.
Publicado: (2020)

Diagnosis and management of subcutaneous implantable cardioverter‐defibrillator infections based on process mapping
por: Baddour, Larry M., et al.
Publicado: (2020)

Remote monitoring of implantable cardioverter defibrillators: Patient experiences and preferences for follow‐up
por: Timmermans, Ivy, et al.
Publicado: (2019)

Impact of the COVID‐19 lockdown on the arrhythmic burden of patients with implantable cardioverter‐defibrillators
por: Sassone, Biagio, et al.
Publicado: (2021)

Long-Term Follow-Up of Patients with Chronic Chagas Disease and Implantable Cardioverter-Defibrillator
por: Pereira, Francisca Tatiana Moreira, et al.
Publicado: (2014)

Healthcare utilization in patients with first‐time implantable cardioverter defibrillators (data from the WEBCARE study)
por: Broers, Eva R., et al.
Publicado: (2019)

Ventricular tachycardia as presenting arrhythmia as a determinant of appropriate implantable cardioverter-defibrillator therapy in secondary prevention
por: Noordman, A B P, et al.
Publicado: (2023)

Association between implantable cardioverter-defibrillator and survival in patients awaiting heart transplantation: A meta-analysis and systematic review
por: Lin, Andrew Y., et al.
Publicado: (2021)

Implantable cardioverter-defibrillator–related procedures and associated complications in continuous flow left ventricular assist device recipients: A multicenter experience
por: Ravichandran, Ashwin, et al.
Publicado: (2021)

Standard and extended electrocardiographic screening for the subcutaneous implantable cardioverter-defibrillator
por: Lewandowski, M, et al.
Publicado: (2023)

Subcutaneous implantable cardioverter-defibrillator generator removal: a multicenter analysis
por: Luker, J, et al.
Publicado: (2023)

Effect of cardiac resynchronization therapy with implantable cardioverter defibrillator versus cardiac resynchronization therapy with pacemaker on mortality in heart failure patients: results of a high-volume, single-centre experience
por: Kutyifa, Valentina, et al.
Publicado: (2014)

Subcutaneous Implantable Cardioverter-Defibrillator Shock: Appropriate or Inappropriate?
por: Ip, James E.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rj968po0u506pcutnqlv0sc70k